The molecular basis of NOD2 susceptibility mutations in Crohn's disease
Open Access
- 1 November 2008
- journal article
- review article
- Published by Elsevier in Mucosal Immunology
- Vol. 1 (1), S5-S9
- https://doi.org/10.1038/mi.2008.42
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitisJournal of Clinical Investigation, 2008
- NOD2 Transgenic Mice Exhibit Enhanced MDP-Mediated Down-Regulation of TLR2 Responses and Resistance to Colitis InductionGastroenterology, 2007
- Nucleotide Binding Oligomerization Domain 2 Deficiency Leads to Dysregulated TLR2 Signaling and Induction of Antigen-Specific ColitisImmunity, 2006
- Signalling pathways and molecular interactions of NOD1 and NOD2Nature Reviews Immunology, 2005
- The Crohn's Disease Protein, NOD2, Requires RIP2 in Order to Induce Ubiquitinylation of a Novel Site on NEMOCurrent Biology, 2004
- NOD2 is a negative regulator of Toll-like receptor 2–mediated T helper type 1 responsesNature Immunology, 2004
- Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's diseaseNature, 2001
- A frameshift mutation in NOD2 associated with susceptibility to Crohn's diseaseNature, 2001